RGSKGlaxoSmithKline Tokenized Stock (Reality)

GSK engages in the scientific R&D and commercialized production of prescription drugs and vaccines. The core business focuses on infectious disease prevention, immuno-inflammatory regulation, respiratory system diseases, and oncology treatments. The company screens active compounds in laboratories and advances human clinical validation, subsequently scaling up preparation in biochemical factories. Approved pharmaceutical and vaccine products are sold through formal supply chains to medical institutions and government procurement agencies across various countries.

• Macro context: RGSK is part of the tokenized equities market, which represents only ~0.002% of global listed equity today.

Data as of Nov 1, 2026